Technical calls by Religare Broking: Buy Dr Reddy's Lab, Ramco Cements

Weekly Technical Recommendations by Religare Broking Ltd.

Markets, Buy, Sell, Stocks, Shares
Photo: Shutterstock.com
Religare Broking Mumbai
2 min read Last Updated : Nov 06 2019 | 7:53 AM IST
Buy Dr. Reddy's Laboratories Limited

Last Close: Rs 2,815.70
 
Initiation range: Rs 2,790-2,800
 
Target: Rs 2,960
 
Stop loss: Rs 2,710
 
DRREDDY has been consolidating in a range while holding firmly above the support zone of moving averages ribbon (50, 100 and 200 EMA) on the multiple time frames. Indications are now in the favor of breakout ahead. We advise initiating fresh longs in the given range.

Also Read


Buy The Ramco Cements Limited

Last Close: Rs 791.05
 
Initiation range: Rs 775-785

Target: Rs 840
 
Stop loss: Rs 760
 
RAMCOCEM has formed a cup and handle pattern (which generally act as a continuous pattern) on the weekly chart while holding above the support zone of long term moving averages. After the recent surge from its crucial support zone around 690 levels, it has witnessed a marginal dip, offering fresh buying opportunity to those who missed the chance earlier. We advise accumulating in the mentioned zone.

Buy Tata Chemicals Limited

Last Close: Rs 636.85
 
Initiation range: Rs 620-625

Target: Rs 665

Stop loss: Rs 605
 
Post breakout from its nine-month long consolidation phase, TATACHEM is currently consolidating around its major support zone of long term moving averages on daily chart. The chart pattern combined with positioning of the confirmation indicators is now pointing towards steady rise ahead. We thus suggest initiating fresh longs as per the mentioned levels.

Sell November Futures of Canara Bank

Last Close: Rs 207.15

Initiation range: Rs 209-211

Target: Rs 195

Stop loss: Rs 216

In line with other PSU banking counters, CANBK has also witnessed decent recovery of late and reached closer to its immediate hurdle of 100 EMA on the daily chart. Considering its chart pattern and overall downtrend, we see this rebound as shorting opportunity and expect decline to resume. We thus suggest traders to initiate fresh shorts within the mentioned zone.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Ramco CementsTata ChemicalsDr Reddy stockDr Reddystechnical analysisstocks technical analysisStock CallStock calls

Next Story